Trademarkia Logo

Canada

C$
Trademark Search in Canada
STAR BLACK & WHITE DESIGN

View On IC.GC.CA

STAR BLACK & WHITE DESIGN
REGISTERED

on 25 Oct 2019

Last Applicant/ Owned by

BIONTECH US INC.

8 The Green Suite BDover, Delaware 19901

US

Serial Number

1859289 filed on 25th Sept 2017

Registration Number

TMA1060661 registered on 25th Oct 2019

Registration expiry Date

25th Oct 2029

Correspondent Address

SMART & BIGGAR LP

1000 RUE DE LA GAUCHETIERE OUESTBUREAU 3300MONTREAL

QUÉBEC

CA

H3B4W5

STAR BLACK & WHITE DESIGN

Trademark usage description

pharmaceuticals, namely, immunotherapies for the treatment of cancer and oncological conditions; oncological preparations, namely, pharmaceutical prod Read More

Vienna Information

1 . 1 . 1

StarsÉtoiles

1 . 1 . 2

One starUne étoile

1 . 1 . 12

Stars with uneven points -- Note: Including sparks consisting of uneven-pointed stars.Étoiles à pointes irrégulières -- Note: Y compris les étincelles constituées d'étoiles à pointes irrégulières.

1 . 1 . 10

Stars with more than four pointsÉtoiles à plus de quatre pointes

26 . 3 . 23

Lines or bands forming an angle -- Note: Including chevrons and arrowheads formed by lines or bands.Lignes ou bandes formant un angle -- Note: Y compris les chevrons et les pointes de flèches formées par des lignes ou des bandes.

Classification Information

Class [005]
Pharmaceuticals, namely, immunotherapies for the treatment of cancer and oncological conditions; oncological preparations, namely, pharmaceutical products for the detection, prevention, and treatment of cancer; anti-cancer preparations; biological preparations for the treatment of cancer and oncological conditions; pharmaceutical products for the prevention and treatment of cancer and oncological conditions; synthetic peptides for the treatment of cancer and oncological conditions; and vaccine preparations

Classification kind code

11

Class [042]
Conducting early evaluations in the field of new pharmaceuticals; consulting services in the fields of biotechnology and pharmaceutical research; pharmaceutical product development services; pharmaceutical product evaluation services; pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development of pharmaceuticals for the treatment of cancer and oncological conditions; research and development of vaccines and medicines; technical research in the field of pharmaceutical studies; platform technology, namely, a medical platform for the development and manufacturing of cancer immunotherapies using bioinformatics, peptide chemistry, and cell biology; conducting clinical trials for others in the field of pharmaceuticals for the treatment and prevention of cancer and oncological conditions; and consulting services for others in the field of design, planning, and implementation of clinical trials

Classification kind code

11

Class [044]
Consultancy services for medical professionals relating to the use of therapeutic properties of pharmaceuticals for the treatment of cancer and oncological conditions; and providing information relating to therapeutic properties of pharmaceuticals

Classification kind code

11

Mark Details

Serial Number

1859289

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 67
on 11th Sept 2019		Agent Name Changed
Submitted for opposition 42
on 17th Jul 2019		Advertised
Submitted for opposition 26
on 27th Jun 2019		Approved
Submitted for opposition 15
on 4th Jun 2019		Correspondence Created
Submitted for opposition 27
on 9th May 2019		Approval Notice Sent
Submitted for opposition 22
on 29th Oct 2018		Search Recorded
Submitted for opposition 20
on 29th Oct 2018		Examiner's First Report
Submitted for opposition 31
on 27th Sept 2017		Formalized
Submitted for opposition 1
on 26th Sept 2017		Created
Submitted for opposition 30
on 25th Sept 2017		Filed